Our Mission:
To Develop Breakthrough Treatments for Human Disease

Benefits to Patients

Witnessing Lexicon’s drug candidates provide benefits in patients is gratifying and validates our strategy.
-Brian Zambrowicz, Chief Scientific Officer

Commitment to Excellence

Lexicon's commitment to utilizing the best science, and a strong team-based culture, is fundamental to our strategy of discovering first-in-class and best-in-class drugs that will improve the lives of patients.
-Alan Wilson, VP, DMPK

Unique Pipeline of Drug Candidates

I believe Lexicon’s unique pipeline of first-in-class drug candidates will provide substantial value to both partners and patients.
-Jeff Wade, EVP, Corporate Development & CFO

Collaborative Spirit

Through the collaborative spirit that is pervasive at Lexicon, a CPA feels as intrinsically important as a chemist to the success of the company.
-Jim Tessmer, VP, Finance & Accounting
 

About Us

Lexicon is a biopharmaceutical company with clinical-stage drug programs for diabetes, carcinoid syndrome, and other indications.

 
 
 

Clinical Trials

Lexicon is planning and conducting multiple clinical trials. To learn more about these studies click here.

 
 
 

Investors

Lexicon Pharmaceuticals is a biopharmaceutical company focused on drug discovery and development. Click here to view our stock price, company events, webcasts and more.

 
 
 

Careers

Lexicon is an exciting and innovative place to work. Click here to learn more about job openings, company culture and more.